Orgenesis Inc.
NASDAQ:ORGS
0.59 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.53 | 36.025 | 35.502 | 7.652 | 33.256 | 18.655 | 10.089 | 6.397 | 2.974 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 6.255 | 20.44 | 28.16 | 30.618 | 18.116 | 10.698 | 6.807 | 7.657 | 3.88 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 |
| Gross Profit
| -5.725 | 15.585 | 7.342 | -22.966 | 15.14 | 7.957 | 3.282 | -1.26 | -0.906 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 |
| Gross Profit Ratio
| -10.802 | 0.433 | 0.207 | -3.001 | 0.455 | 0.427 | 0.325 | -0.197 | -0.305 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 10.623 | 6.01 | 36.644 | 83.986 | 12.458 | 6.464 | 2.478 | 2.157 | 1.067 | 1.693 | 1.64 | 2.309 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 35.088 | 16.155 | 15.397 | 19.353 | 25.25 | 16.609 | 10.686 | 6.448 | 4.035 | 2.884 | 3.82 | 2.68 | 0.072 | 0.021 | 0.026 | 0 |
| Selling & Marketing Expenses
| 0.464 | -0.566 | -0.687 | -0.38 | 1.148 | 1.212 | 0.599 | 0.397 | 0.326 | 0.144 | 0.188 | 0.141 | 0 | 0 | 0 | 0 |
| SG&A
| 35.088 | 16.155 | 14.71 | 18.973 | 25.25 | 16.609 | 10.686 | 6.448 | 4.035 | 2.884 | 3.82 | 2.68 | 0.072 | 0.021 | 0.026 | 0.003 |
| Other Expenses
| 0.004 | 0.788 | -1.33 | 0.474 | 2.036 | -1.017 | 1.631 | 2.117 | 1.203 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 |
| Operating Expenses
| 49.166 | 22.953 | 50.024 | 103.433 | 39.744 | 22.056 | 14.795 | 10.225 | 6.305 | 4.577 | 5.461 | 4.989 | 0.072 | 0.021 | 0.026 | 0.003 |
| Operating Income
| -53.636 | -7.368 | -42.682 | -95.781 | -24.604 | -14.65 | -11.23 | 11.277 | -7.211 | -4.577 | -5.461 | -4.989 | -0.072 | -0.021 | -0.026 | -0.004 |
| Operating Income Ratio
| -101.2 | -0.205 | -1.202 | -12.517 | -0.74 | -0.785 | -1.113 | 1.763 | -2.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -7.38 | -4.592 | 24.731 | -0.955 | -0.874 | -0.908 | -0.874 | 1.433 | 2.546 | 0.17 | 0.1 | -0.519 | 0 | -0.015 | 0 | 0 |
| Income Before Tax
| -64.445 | -11.96 | -17.951 | -96.736 | -25.478 | -17.767 | -13.677 | -10.741 | -5.361 | -5.504 | -5.539 | -4.998 | -0.072 | -0.036 | -0.026 | -0.004 |
| Income Before Tax Ratio
| -121.594 | -0.332 | -0.506 | -12.642 | -0.766 | -0.952 | -1.356 | -1.679 | -1.803 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.473 | 0.209 | 0.108 | -1.609 | 0.563 | 1.337 | -1.31 | -1.547 | -0.9 | 0.691 | 0.173 | 0.01 | 0 | 0 | 0 | 0 |
| Net Income
| -55.361 | -12.169 | -18.059 | -95.127 | -26.041 | -18.291 | -12.367 | -9.194 | -4.461 | -5.504 | -5.539 | -4.998 | -0.072 | -0.036 | -0.026 | -0.004 |
| Net Income Ratio
| -104.455 | -0.338 | -0.509 | -12.432 | -0.783 | -0.98 | -1.226 | -1.437 | -1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.91 | -0.48 | -0.74 | -4.46 | -1.64 | -1.37 | -1.28 | -1.08 | -0.96 | -1.22 | -1.32 | -1.11 | -0.011 | -0.005 | -0.004 | -0.001 |
| EPS Diluted
| -1.91 | -0.48 | -0.74 | -4.46 | -1.64 | -1.37 | -1.27 | -1.08 | -0.94 | -1.21 | -1.32 | -1.11 | -0.011 | -0.005 | -0.004 | -0.001 |
| EBITDA
| -54.068 | -6.9 | -13.846 | -95.197 | -20.861 | -12.213 | -10.186 | -8.685 | -5.22 | -4.979 | -5.463 | -4.987 | -0.072 | -0.006 | -0.026 | -0.004 |
| EBITDA Ratio
| -102.015 | -0.192 | -0.39 | -12.441 | -0.627 | -0.655 | -1.01 | -1.358 | -1.755 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |